PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy
2017 · Oncogene · 123 citations
https://doi.org/10.1038/onc.2017.326
P
P Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
224
Citations
3
h-index
3
i10-index
P Liu is an academic researcher from Beijing Radiation Center. The author has contributed to research in topics: HER2/EGFR in Cancer Research & PI3K/AKT/mTOR signaling in cancer & MicroRNA in disease regulation. The author has an h-index of 3, co-authored 5 publications.
Papers by this author
worksPI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers
2015 · Oncogene · 42 citations
https://doi.org/10.1038/onc.2015.406
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS4
2024 · Thrombosis Journal · 1 citations
https://doi.org/10.1186/s12959-024-00615-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat